A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted ActivityJonathan Rios‐Doria(Incyte (United States)), Holly K. Koblish(Incyte (United States))Frontiers in OncologyDecember 7, 202010.3389/fonc.2020.598477Cited by 42SaveCiteExport RISWatch citationsRelated PapersPreclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies|PLoS ONE|2018|53